The pathobiological behaviors and prognosis associated with Japanese gastric adenocarcinomas of pure WHO histological subtypes

Histology and Histopathology

Volumn 25, Issue 4, 2010, Pages 445-452

  Zheng, Hua Chuan ^a   Zheng, Yu Shuang ^a   Xia, Pu ^a   Xu, Xiao Yan ^a   Xing, Ya Nan ^a   Takahashi, Hiroyuki ^b   Guan, Yi Fu ^a   Takano, Yasuo ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Gastric carcinoma; Pathobiological behaviors; Prognosis; WHO histological classification

Indexed keywords

TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CLASSIFICATION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GASTRECTOMY; HUMAN; JAPAN; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PAPILLARY CARCINOMA; PATHOLOGY; PROGNOSIS; SIGNET RING CARCINOMA; STOMACH TUMOR; SURVIVAL RATE; TISSUE MICROARRAY; WORLD HEALTH ORGANIZATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; CARCINOMA, SIGNET RING CELL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; GASTRECTOMY; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; WORLD HEALTH ORGANIZATION;

EID: 77950263359     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Adachi Y., Yasuda K., Inomata M., Sato K., Shiraishi N. and Kitano S. (2000). Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type. Cancer 89, 1418-1424.
2. Aihara R., Mochiki E., Kamiyama Y., Kamimura H., Asao T. and Kuwano H. (2004). Mucin phenotypic expression in early signet ring cell carcinoma of the stomach: its relationship with the clinicopathologic factors. Dig. Dis. Sci. 49, 417-424.
3. Cozzi P.J., Wang J., Delprado W., Perkins A.C., Allen B.J., Russell P.J. and Li Y. (2005). MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. Clin. Exp. Metastasis 22, 565-573.
4. Crew K.D. and Neugut A.I. (2006). Epidemiology of gastric cancer. World J. Gastroenterol. 12, 354-362.
5. Goseki N., Takizawa T. and Koike M. (1992). Differences in the mode of the extension of gastric cancer classified by histological type: new histological classification of gastric carcinoma. Gut 33, 606-612.
6. Hamilton S.R. and Aaltonen L.A. (2000). WHO classification of tumors: pathology and genetics of tumors of the digestive system. IARC press. Lyon, France.
7. Hyung W.J., Noh S.H., Lee J.H., Huh J.J., Lah K.H., Choi S.H. and Min J.S. (2002). Early gastric carcinoma with signet ring cell histology. Cancer 94, 78-83.
8. Inoue M. and Tsugane S. (2005). Epidemiology of gastric cancer in Japan. Postgrad. Med. J. 81, 419-424.
9. Kaneko S. and Yoshimura T. (2001). Time trend analysis of gastric cancer incidence in Japan by histological types, 1975-1989. Br. J. Cancer 84, 400-405.
10. Kelley J.R. and Duggan J.M. (2003). Gastric cancer epidemiology and risk factors. J. Clin. Epidemiol. 56, 1-9.
11. Kumada T., Tsuneyama K., Hatta H., Ishizawa S. and Takano Y. (2004). Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital. Mod. Pathol. 17, 1141-1149.
12. Kunisaki C., Akiyama H., Nomura M., Matsuda G., Otsuka Y., Ono H.A. and Shimada H. (2006). Clinicopathologic characteristics and surgical outcomes of mucinous gastric carcinoma. Ann. Surg. Oncol. 13, 836-842.
13. Lauren P. (1965). The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol. Microbiol.Scand. 64, 31-49.
14. Li X., Zheng H., Hara T., Masuda S., Wang Z., Yang X., Guan Y. and Takano Y. (2008a). Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas. Int. J. Oncol. 33, 69-79.
15. Li X.H., Zheng H.C., Wang Z.G., Takahashi H., Yang X.H., Guan Y.F. and Takano Y. (2008b). The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays. Anticancer Res. 28, 1061-1067.
16. Ming S.C. (1977). Gastric carcinoma: A pathobiological classification. Cancer 39, 2475-2485
17. Nakamura K., Sugano H. and Kato Y.(1968). Carcinoma of the stomach in the incipient phase: Its histogenesis and histological appearance. GANN 59, 251-258.
18. Roy P., Piard F., Dusserre-Guion L., Martin L., Michiels-Marzais D. and Faivre J. (1998). Prognostic comparison of the pathological classifications of gastric cancer: a population-based study. Histopathology 33, 304-310.
19. Shinohara T., Ohshima K., Murayama H., Kikuchi M., Yamashita Y. and Shirakusa T. (1996). Apoptosis and proliferation in gastric carcinoma: the association with histological type. Histopathology 29,123-129.
20. Sobin L.H. and Wittekind C.H. (2002). TNM classification of malignant tumors. 6th edn. John Wiley & Sons, Hoboken. New Jersey.
21. Sugihara H., Tsuchihashi Y., Hattori T., Fukuda M. and Fujita S. (1985). Cell proliferation and cell loss in intramucosal signet ring cell carcinoma of canine stomachs induced by N-ethyl-N'-nitro-N-nitrosoguanidine. J. Cancer. Res. Clin. Oncol. 110, 87-94.
22. Yu M., Zheng H., Tsuneyama K., Takahashi H., Nomoto K., Xu H. and Takano Y. (2007). Paradoxical expression of maspin in gastric carcino-mas: correlation with carcinogenesis and progression. Hum. Pathol. 38, 1248-1255.
23. Zhang Y.C., Zhang P.F. and Chen J.Q. (1964). Morphological and biological characteristics of 60 gastric carcinomas. Zhonghua Bing Li Xue Za Zhi 8, 243-247.
24. Zheng H., Takahashi H., Nakajima T., Murai Y., Cui Z., Nomoto K., Tsuneyama K. and Takano Y. (2006a). MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays. J. Cancer Res. Clin. Oncol. 132, 817-823.
25. Zheng H., Tsuneyama K., Cheng C., Takahashi H., Cui Z., Murai Y., Nomoto K. and Takano Y. (2006b). An immunohistochemical study of p53 and Ki-67 in gastrointestinal adenoma and adenocarcinoma using tissue microarray. Anticancer Res. 26, 2353-2360.
26. Zheng H., Saito H., Masuda S., Yang X. and Takano Y. (2007a). Phosphorylated GSK3beta-ser9 and EGFR are good prognostic factors for lung carcinomas. Anticancer Res. 27, 3561-3569.
27. Zheng H., Takahashi H., Murai Y., Takahashi H., Masuda S., Wang Z., Yang X., Guan Y. and Takano Y. (2007b). Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray. J. Clin. Pathol. 60, 273-277.
28. Zheng H.C., Sun J.M., Wei Z.L., Yang X.F., Zhang Y.C. and Xin Y. (2003). Expression of Fas ligand and caspase-3 contributes to formation of immune escape in gastric cancer. World J. Gastroenterol. 9,1415-1420.
29. Zheng H.C., Takahashi H., Murai Y., Cui Z.G., Nomoto K., Miwa S., Tsuneyama K. and Takano Y. (2006c). Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis. Br. J. Cancer 95,1371-1378.
30. Zheng H.C., Takahashi H., Li X.H., Hara T., Masuda S., Guan Y.F. and Takano Y. (2008a). Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas. Hum. Pathol. 39, 1042-1049.
31. Zheng H.C., Takahashi H., Li X.H., Masuda S., Guan Y.F. and Takano Y. (2008b). Downregulated parafibromin expression is a promising marker for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas. Virchows Arch. 452, 147-155.
32. Zheng H.C., Zheng Y.S., Li X.H., Takahashi H., Hara T., Masuda S., Yang X.H., Guan Y.F. and Takano Y. (2008c). Arp2/3 overexpression contributesed to pathogenesis, growth and invasion of gastric carcinoma. Anticancer Res. 28, 2225-2232.
33. Zheng H.C., Li X.H., Hara T., Masuda S., Yang X.H., Guan Y.F. and Takano Y. (2008d). Mixed-type gastric carcinomas exhibit more aggressive features and indicate the histogenesis of carcinomas. Virchows Arch. 452, 525-534.